Highmark Commercial Medical Policy - Pennsylvania


 
Printer Friendly Version

Medical Policy: E-31-026
Topic: Negative Pressure Wound Therapy (NPWT) Pumps/Vacuum Assisted Closure (VAC) of Chronic Wounds
Section: Durable Medical Equipment
Effective Date: October 1, 2017
Issue Date: August 20, 2018
Last Reviewed: August 2018

The purpose of the NPWT device is to promote wound healing. Wound healing is defined as improvement occurring in either surface area or depth of the wound. Lack of improvement of a wound is defined as a lack of progress in quantitative measurements of wound characteristics including wound length and width (surface area), or depth measured serially and documented over a specified time interval.

This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Policy Position Coverage is subject to the specific terms of the member’s benefit plan.

NPWT pumps/VAC for nonhealing wounds may be considered medically necessary when the following conditions are met:

Ulcers and Wounds in the Outpatient Setting

  • Chronic, nonhealing stage III or IV pressure ulcer, neuropathic (e.g., diabetic) ulcer, venous or arterial insufficiency ulcer, or chronic ulcer of mixed etiology (i.e., present for at least 30 days); and
  • Wound therapy program, as described below, (applicable to the type of wound) have been tried or considered and ruled out prior to application of NPWT pumps/VAC.
    • All ulcers or wound types (i.e., surgically created, traumatic), must include ALL of the following therapeutic measures addressed, applied, or considered and ruled out prior to application of NPWT pumps/VAC:
      • Documentation in the patient's medical record of evaluation, care and wound measurements by a licensed medical professional  (i.e., physician, PA, CRNP, RN, LPN, RPT); and
      • Application of dressings to maintain a moist wound environment; and
      • Debridement of necrotic tissue if present; and
      • Evaluation of and provision for adequate nutritional status; or
    • Chronic stage III or IV pressure ulcers:
      • The patient has been on an appropriately turned and positioned schedule; and
      • The patient has used a support surface for pressure ulcers on the trunk or pelvis; and
      • The patient's moisture and incontinence have been appropriately managed; or
    • Neuropathic (e.g., diabetic, ulcers)
      • The patient has been on a comprehensive diabetic management program; and
      • Reduction in pressure on a foot ulcer has been accomplished with appropriate modalities (i.e., saline wet-to-dry dressings; debridement etc.); and
      • Appropriate foot care (i.e., visual inspection, appropriate foot wear, etc.); or
    • Venous or arterial insufficiency ulcers:
      • Compression bandages and/or garments have been consistently applied; and
      • Leg elevation and ambulation have been encouraged; or
    • Surgically created wound or traumatic wound:
      • The wound requires accelerated formation of granulation tissue that cannot be achieved by other available topical wound treatments (e.g., comorbidities that prevent healing); and
      • Results of previous wound treatments are documented.

Ulcers and Wounds Encountered in an Inpatient Setting

  • NPWT pumps/VAC may be considered medically necessary when continuation of treatment is ordered beyond discharge to the home setting.
  • An ulcer or wound is encountered in the inpatient setting and after wound treatments have been tried or considered and ruled out, NPWT pumps/VAC is initiated because it is considered, in the judgment of the treating physician, the best available treatment option.
  • Complications of a surgically created wound (e.g., dehiscence, post-sternotomy disunion with exposed sternal bone, etc.) or traumatic wound, (e.g., preoperative flap or graft, exposed bones), where there is documentation of the medical necessity for accelerated formation of granulation tissue which cannot be achieved by other available topical wound treatments (e.g., other conditions that will not allow for healing times achievable with other topical wound treatments).

If the above criteria are not met for the use of NPWT pumps/VAC systems in either setting, the pump and supplies will be considered not medically necessary.

NPWT pumps/VAC systems and their supplies used in the treatment of children from birth up to and including 12 years of age are considered experimental/investigational and, therefore, non-covered. According to the U.S. Food and Drug Administration (FDA), the safety and effectiveness of NPWT pumps/VAC systems in newborns, infants and children (greater than or equal to 12 years of age) has not been established at this time. Currently there are no NPWT pumps/VAC systems cleared for use in these populations.

Procedure Codes
97605, 97606, 97607, 97608, A6550, A7000, E2402, K0743, K0744, K0745, K0746



Supplies
Supplies for NPWT pumps/VAC are limited to the following. Requests for amounts greater than the stated limits will be denied as not medically necessary.

  • Fifteen (15) dressing kits per wound per month - Additional dressing kits per month must be supported by documentation that the wound size requires more than one dressing kit for each dressing change.
  • Ten (10) canister sets per month - Additional canister sets per month must be supported by documentation that a large volume of drainage (greater than 90 ml of exudate per day) requires more than one canister set.
Procedure Codes
A6550, A7000, K0743, K0744, K0745, K0746



The NPWT pumps/VAC must be prescribed by a physician and be capable of accommodating more than one (1) wound dressing set for multiple wounds on a individual. Therefore, more than one (1) pump billed per individual for the same time period will be considered not medically necessary.

Procedure Codes
E2402



The pump and supplies will be considered not medically necessary with ANY of the following, whichever occurs first:

  • Adequate wound healing has occurred to the degree that NPWT pumps/VAC may be discontinued, in the judgment of the treating physician; or
  • Any measurable degree of wound healing has failed to occur over the prior month as documented in the individual’s records; or
  • Four (4) months (including the time NPWT was applied in an inpatient setting prior to discharge to the home) have elapsed using an NPWT pumps/VAC device in the treatment of any wound.

Coverage beyond four (4) months will be given individual consideration based upon additional documentation.

This additional documentation must address the initial condition of the wound including measurements, efforts to address all aspects of wound care, subsequent monthly wound measurements, and what changes in wound therapy are being applied to effect wound healing. This information must be updated with each subsequent request for additional months of use of NPWT pumps/VAC.

Procedure Codes
97605, 97606, 97607, 97608, A6550, A7000, E2402, K0743, K0744, K0745, K0746



All other uses of NPWT pumps/VAC systems for the treatment of chronic wounds are considered not medically necessary.



Place of Service: Inpatient/Outpatient

NPWT pumps/VAC of chronic wounds is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.


The policy position applies to all commercial lines of business


Denial Statements

Services that do not meet the criteria of this policy will not be considered medically necessary. A network provider cannot bill the member for the denied service unless: (a) the provider has given advance written notice, informing the member that the service may be deemed not medically necessary; (b) the member is provided with an estimate of the cost; and (c) the member agrees in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.

Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.

Links





Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:
  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
    • Qualified sign language interpreters
    • Written information in other formats (large print, audio, accessible electronic formats, other formats)
  • Provides free language services to people whose primary language is not English, such as:
    • Qualified interpreters
    • Information written in other languages
If you need these services, contact the Civil Rights Coordinator.

If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201
1-800-368-1019, 800-537-7697 (TDD)

Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.

Insurance or benefit/claims administration may be provided by Highmark, Highmark Choice Company, Highmark Coverage Advantage, Highmark Health Insurance Company, First Priority Life Insurance Company, First Priority Health, Highmark Benefits Group, Highmark Select Resources, Highmark Senior Solutions Company or Highmark Senior Health Company, all of which are independent licensees of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans.

Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.



back to top